Promopharm S.A. - Hikma
WEBPromopharm S.A est l'entité légale de Hikma au Maroc, qui produit et distribue des produits pharmaceutiques génériques et dermo cosmétiques haut de gamme.
Page d'accueil - Hikma
WEBPromopharm S.A. est l'entité légale de Hikma au Maroc, qui fabrique et commercialise ses produits pharmaceutiques et ceux de nous partenaires.
Hikma Enters the Moroccan Market Through the Acquisition of …
WEBOct 3, 2011 · Hikma will utilise Promopharm's strong commercial and distribution platform, leveraging its excellent relationships with pharmacies, wholesalers, distributors and licensors.
Hikma Buys 63.9% Stake in Morocco’s Promopharm as Start of Takeover …
WEBOct 4, 2011 · Hikma paid an aggregate of $111.2 million to acquire a 63.9% stake in Moroccan pharma firm Promopharm (Société de Promotion Pharmaceutique du Maghreb).
Hikma Pharmaceuticals - Wikipedia
WEBHikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman , Jordan in 1978.
Hikma enters Moroccan market via $111 million controlling stake …
WEBOct 5, 2011 · Jordan-headquartered Hikma Pharmaceuticals (LSE: HIK) says that it has acquired 63.9% of Promopharm (Societe de Promotion Pharmaceutique du Maghreb; Casablanca: PRO) from a consortium of shareholders, comprising existing management, institutions and related parties, for an aggregate cash consideration of …
Moroccan tonic for Hikma - Financial Times
WEBOct 4, 2011 · Late on Monday it announced plans to buy a $111.2m controlling stake in Morocco’s Societe de Promotion Pharmaceutique du Maghreb (Promopharm) to secure access to one of the Arab world’s more...
Brahim Oulammou – Director General, Promopharm (a Hikma …
WEBApr 16, 2015 · The director general of Promopharm explains why Hikma decided to invest in the Moroccan market, why we have to take a long-term perspective when judging the government’s reform agenda and how the main priority will always be responding to patient needs. In 2011 Hikma acquired a 63.9 percent stake in Promopharm.
Hikma moves into Morocco with $111M deal - Fierce Pharma
WEBOct 4, 2011 · Jordan's Hikma Pharmaceuticals has made its first foray into Morocco with a $111 million deal for controlling interest in Promopharm, the country's 9th-largest drugmaker with 200 branded...
WEBPromopharm S.A, filiale du groupe Hikma, a fait preuve d'une résilience remarquable en 2022. Notre résultat net a augmenté de +9% et notre chiffre d'affaires de +12%.
Skip to content